Examen de radiation de la TSX - Acerus Pharmaceuticals Corporation (ASP)
Issuer: | Acerus Pharmaceuticals Corporation |
Securities: | Common Shares (the "Securities") |
Symbol(s): | ASP |
Delisting Date: | March 3, 2023 (at the close) |
Reason: | Failure to meet continued listing requirements. |
Trading Status: | The Securities will remain suspended from trading. |
Additional Information: | TSX Bulletin 2023-0057 dated January 26, 2023. |
TSX contact: | Selma Thaver, Director, TSX Listings |